GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bespoke Extracts Inc (OTCPK:BSPK) » Definitions » Current Ratio

BSPK (Bespoke Extracts) Current Ratio : 0.07 (As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Bespoke Extracts Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Bespoke Extracts's current ratio for the quarter that ended in Sep. 2024 was 0.07.

Bespoke Extracts has a current ratio of 0.07. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Bespoke Extracts has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.

The historical rank and industry rank for Bespoke Extracts's Current Ratio or its related term are showing as below:

BSPK' s Current Ratio Range Over the Past 10 Years
Min: 0.03   Med: 0.31   Max: 77.2
Current: 0.07

During the past 13 years, Bespoke Extracts's highest Current Ratio was 77.20. The lowest was 0.03. And the median was 0.31.

BSPK's Current Ratio is ranked worse than
97.86% of 1027 companies
in the Drug Manufacturers industry
Industry Median: 1.99 vs BSPK: 0.07

Bespoke Extracts Current Ratio Historical Data

The historical data trend for Bespoke Extracts's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bespoke Extracts Current Ratio Chart

Bespoke Extracts Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Dec22 Dec23
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.34 0.20 0.16 0.13 0.08

Bespoke Extracts Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.08 0.08 0.09 0.07

Competitive Comparison of Bespoke Extracts's Current Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Bespoke Extracts's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bespoke Extracts's Current Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bespoke Extracts's Current Ratio distribution charts can be found below:

* The bar in red indicates where Bespoke Extracts's Current Ratio falls into.


;
;

Bespoke Extracts Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Bespoke Extracts's Current Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Current Ratio (A: Dec. 2023 )=Total Current Assets (A: Dec. 2023 )/Total Current Liabilities (A: Dec. 2023 )
=0.082/1.079
=0.08

Bespoke Extracts's Current Ratio for the quarter that ended in Sep. 2024 is calculated as

Current Ratio (Q: Sep. 2024 )=Total Current Assets (Q: Sep. 2024 )/Total Current Liabilities (Q: Sep. 2024 )
=0.124/1.728
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bespoke Extracts  (OTCPK:BSPK) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Bespoke Extracts Current Ratio Related Terms

Thank you for viewing the detailed overview of Bespoke Extracts's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bespoke Extracts Business Description

Traded in Other Exchanges
N/A
Address
12001 E. 33rd Avenue, Unit O, Aurora, Denver, CO, USA, 80010
Bespoke Extracts Inc is focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products. It unveiled a new brand image and a new line-up of seven hemp-derived CBD formulations available for purchase in the form of tinctures and softgels.
Executives
Michael Feinsod director, 10 percent owner, officer: CEO
Tyler Hunter Garth director, officer: President 6300 E HAMPDEN AVE, 2306, DENVER CO 80222
Danil Pollack 10 percent owner, officer: President and CEO 6 GAUGUIN AVE., VAUGHAN A6 L4J9J7
Niquana Monique Noel 10 percent owner, officer: President and CEO 1316 SW 3RD COURT, FT. LAUDERDALE FL 33312
Marc Yahr director, 10 percent owner, officer: President and CEO 1966 NE 123RD STREET, NUM 170, NORTH MIAMI FL 33181
Anthony Ivankovich 10 percent owner 971 CRANDON BLVD., APT. PH-6, KEY BISCAYNE FL 33149
Mcglothlin Holdings, Ltd. 10 percent owner 402 W. DAVIS, LULING TX 78648
Barry Tenzer director, 10 percent owner, officer: President, CEO, CFO 290 LENOX AVENUE, NEW YORK NY 10027
Roberto Fata director, 10 percent owner, officer: Executive VP 290 LENOX AVENUE, SECOND FLOOR, NEW YORK NY 10027
Lyle Hauser 10 percent owner 290 LENOX AVENUE, SECOND FLOOR, NEW YORK NY 10027